Crystal structure of misoprostol bound to the labor inducer prostaglandin E 2 receptor
Nat Chem Biol. 2019 Jan;15(1):11-17. doi: 10.1038/s41589-018-0160-y. Epub 2018 Dec 3.
Martin Audet 1, Kate L White 1, Billy Breton 2, Barbara Zarzycka 1, Gye Won Han 1, Yan Lu 3 4, Cornelius Gati 5 6, Alexander Batyuk 7, Petr Popov 1 8 9, Jeffrey Velasquez 1, David Manahan 1, Hao Hu 10, Uwe Weierstall 10, Wei Liu 10, Wenqing Shui 3 4, Vsevolod Katritch 1 8, Vadim Cherezov 1 8, Michael A Hanson 11, Raymond C Stevens 12
PMID: 30510194 PMCID: PMC6289721 DOI: 10.1038/s41589-018-0160-y
Misoprostol is a life-saving drug in many developing countries for women at risk of post-partum hemorrhaging owing to its affordability, stability, ease of administration and clinical efficacy. However, misoprostol lacks receptor and tissue selectivities, and thus its use is accompanied by a number of serious side effects. The development of pharmacological agents combining the advantages of misoprostol with improved selectivity is hindered by the absence of atomic details of misoprostol action in labor induction. Here, we present the 2.5 Å resolution crystal structure of misoprostol free-acid form bound to the myometrium labor-inducing prostaglandin E2 receptor 3 (EP3). The active state structure reveals a completely enclosed binding pocket containing a structured water molecule that coordinates misoprostol’s ring structure. Modeling of selective agonists in the EP3 structure reveals rationales for selectivity. These findings will provide the basis for the next generation of uterotonic drugs that will be suitable for administration in low resource settings.